Intelligence · Patents
Patents expiring in 2037
Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.
- Patents
- 1,615
Quick answer
1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 9700529
Particulate materials
granted -
US 9700519
Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
granted -
US 9700492
Dental composites systems and methods of making the same and using same
granted -
US 9700491
One-part dental adhesive
granted -
US 9700509
Solutions of lipophilic substances, especially medicinal solutions
granted -
US 9700027
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 9701718
Adenovirus serotype 26 and serotype 35 filovirus vaccines
granted -
US 9701713
Compositions and methods for introduction of macromolecules into cells
granted -
US 9701674
Substituted pyrazines as ATR kinase inhibitors
granted -
US 9700708
Maintaining multiple defined physiological zones using model predictive control
granted -
US 9700628
Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins
granted -
US 9700596
Locally released growth factors to mediate motor recovery after stroke
granted -
US 9700561
Drug combinations and uses in treating a coughing condition
granted -
US 9700025
Genetically modified major histocompatibility complex animals
granted -
US 9701963
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 9701946
Purification method for embryo—derived infectious bronchitis virus (IBV)
granted -
US 9707220
Scopolamine for the treatment of depression and anxiety
granted -
US 9707285
Vaccination methods
granted -
US 9707287
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
granted -
US 9707292
Lipids and compositions for the delivery of therapeutics
granted -
US 9707293
Stable aqueous formulations of adalimumab
granted -
US 9707295
Inhalable medicament
granted -
US 9708267
Activators of human pyruvate kinase
granted -
US 9707223
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 9708371
Treatments for gastrointestinal disorders
granted -
US 9707315
Hydrogel implants with varying degrees of crosslinking
granted -
US 9708247
Modulators of the eIF2alpha pathway
granted -
US 9708291
Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl)-(2-chlorophenyl)-methanone
granted -
US 9708310
Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof
granted -
US 9708313
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
granted -
US 9708359
Pyrrolopyrimidine nucleosides and analogs thereof
granted -
US 9708595
Stabilized alpha-galactosidase and uses thereof
granted -
US 9708386
Modified chimeric polypeptides with improved pharmacokinetic properties
granted -
US 9708392
Monoclonal antibodies against orthopoxviruses
granted -
US 9708610
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 9709703
Ophthalmic lens material, ophthalmic lens, and method for making the same
granted -
US 9708296
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted -
US 9708615
Therapeutic compositions
granted -
US 9707252
Synthetic sealants
granted -
US 9707289
Biochemically stabilized HIV-1 ENV trimer vaccine
granted -
US 9707262
Composition with anoxia-tolerant and anti-fatigue effects and use thereof
granted -
US 9707215
Inhibitors of hepatitis C virus polymerase
granted -
US 9707206
Mast cell stabilizers treatment for systemic disorders
granted -
US 9707281
Pharmaceutical compositions and methods for digesting atherosclerotic plaques
granted -
US 9707270
Method for administering ω-conopeptide
granted -
US 9707239
Compounds that modulate oxidative stress
granted -
US 9707199
Heptadecanoic acid supplement to human diet
granted -
US 9707210
Methods of treating muscular dystrophy
granted
Frequently asked questions
How many pharma patents expire in 2037?
1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.